Singh A, Singh P. TERIFLUNOMIDE: A NOVEL ORAL DISEASE-MODIFYING AGENT UNDER INVESTIGATION FOR THE TREATMENT OF MULTIPLE SCLEROSIS. J. Drug Delivery Ther. [Internet]. 2016 Sep. 12 [cited 2026 Apr. 30];6(5):97-102. Available from: https://www.jddtonline.info/index.php/jddt/article/view/1303